Montecito Bank & Trust Bristol Myers Squibb CO Transaction History

Montecito Bank & Trust

  • $573 Million
  • Q4 2024

A detailed history of Montecito Bank & Trust transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Montecito Bank & Trust holds 12,224 shares of BMY stock, worth $722,682. This represents 0.12% of its overall portfolio holdings.

Number of Shares
12,224
Previous 12,224 -0.0%
Holding current value
$722,682
Previous $632,000 9.34%
% of portfolio
0.12%
Previous 0.11%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 31, 2024
BUY
$39.66 - $51.75 $12,810 - $16,715
323 Added 2.71%
12,224 $632,000
Q2 2024

Jul 17, 2024
SELL
$40.25 - $52.99 $28,175 - $37,093
-700 Reduced 5.56%
11,901 $494,000
Q1 2024

Apr 09, 2024
SELL
$47.98 - $54.4 $15,497 - $17,571
-323 Reduced 2.5%
12,601 $683,000
Q4 2023

Jan 05, 2024
SELL
$48.48 - $57.85 $305,811 - $364,917
-6,308 Reduced 32.8%
12,924 $663,000
Q3 2023

Oct 16, 2023
SELL
$57.89 - $64.73 $46,312 - $51,784
-800 Reduced 3.99%
19,232 $1.12 Million
Q2 2023

Jul 25, 2023
SELL
$63.71 - $70.74 $40,710 - $45,202
-639 Reduced 3.09%
20,032 $1.28 Million
Q1 2023

Apr 24, 2023
BUY
$65.71 - $74.53 $2,562 - $2,906
39 Added 0.19%
20,671 $1.43 Million
Q4 2022

Jan 20, 2023
SELL
$68.48 - $81.09 $13,696 - $16,218
-200 Reduced 0.96%
20,632 $1.48 Million
Q2 2022

Aug 01, 2022
BUY
$72.62 - $79.98 $3,631 - $3,999
50 Added 0.24%
20,832 $1.6 Million
Q1 2022

Apr 22, 2022
SELL
$61.48 - $73.72 $10,697 - $12,827
-174 Reduced 0.83%
20,782 $1.52 Million
Q4 2021

Jan 25, 2022
SELL
$53.63 - $62.52 $16,089 - $18,756
-300 Reduced 1.41%
20,956 $1.31 Million
Q3 2021

Oct 28, 2021
BUY
$59.17 - $69.31 $63,844 - $74,785
1,079 Added 5.35%
21,256 $1.26 Million
Q2 2021

Jul 08, 2021
BUY
$61.91 - $67.42 $35,907 - $39,103
580 Added 2.96%
20,177 $1.35 Million
Q1 2021

Apr 26, 2021
SELL
$59.34 - $66.74 $95,952 - $107,918
-1,617 Reduced 7.62%
19,597 $1.24 Million
Q4 2020

Jan 28, 2021
SELL
$57.74 - $65.43 $60,973 - $69,094
-1,056 Reduced 4.74%
21,214 $1.32 Million
Q3 2020

Oct 27, 2020
BUY
$57.43 - $63.64 $11,486 - $12,728
200 Added 0.91%
22,270 $1.34 Million
Q2 2020

Jul 17, 2020
BUY
$54.82 - $64.09 $37,770 - $44,158
689 Added 3.22%
22,070 $1.3 Million
Q1 2020

Apr 23, 2020
BUY
$46.4 - $67.43 $13,177 - $19,150
284 Added 1.35%
21,381 $1.19 Million
Q4 2019

Jan 22, 2020
BUY
$49.21 - $64.19 $39,417 - $51,416
801 Added 3.95%
21,097 $1.35 Million
Q3 2019

Oct 18, 2019
SELL
$42.77 - $50.71 $20,572 - $24,391
-481 Reduced 2.32%
20,296 $1.03 Million
Q2 2019

Jul 05, 2019
SELL
$44.62 - $49.34 $6,603 - $7,302
-148 Reduced 0.71%
20,777 $943,000
Q1 2019

Apr 05, 2019
BUY
$45.12 - $53.8 $90,240 - $107,600
2,000 Added 10.57%
20,925 $998,000
Q4 2018

Feb 05, 2019
SELL
$48.76 - $63.23 $77,333 - $100,282
-1,586 Reduced 7.73%
18,925 $983,000
Q3 2018

Oct 11, 2018
BUY
$55.19 - $62.25 $84,164 - $94,931
1,525 Added 8.03%
20,511 $1.27 Million
Q2 2018

Aug 02, 2018
SELL
$50.53 - $62.98 $146,840 - $183,019
-2,906 Reduced 13.27%
18,986 $1.05 Million
Q1 2018

Apr 23, 2018
BUY
$59.92 - $68.98 $1.31 Million - $1.51 Million
21,892 New
21,892 $1.38 Million
Q4 2017

Feb 13, 2018
SELL
$59.94 - $65.35 $1.07 Million - $1.17 Million
-17,833 Closed
0 $0
Q4 2017

Feb 13, 2018
SELL
$59.94 - $65.35 $117,302 - $127,889
-1,957 Reduced 9.89%
17,833 $1.09 Million
Q3 2017

Oct 23, 2017
BUY
$55.23 - $63.74 $1.09 Million - $1.26 Million
19,790
19,790 $1.26 Million

Others Institutions Holding BMY

# of Institutions
2,612
Shares Held
1.46B
Call Options Held
31.5M
Put Options Held
34.9M
View Full List

About BRISTOL MYERS SQUIBB CO

BMY Quotes by TradingView
  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $126B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Montecito Bank & Trust Portfolio

Follow Montecito Bank & Trust and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Montecito Bank & Trust, based on Form 13F filings with the SEC.

News

Stay updated on Montecito Bank & Trust with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email